Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma
The approval allows Eyenuk’s AI eye screening system, already approved for detection of diabetic retinopathy, to aid millions of additional patients at risk for vision loss LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) — Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for